Related Experiment Videos
[Thyroglobulin (Tg) in normal subjects and patients with thyroid diseases]
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Final overall survival results from EORTC 1333/PEACE-3 trial of enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Challenges in myasthenia gravis diagnosis: an analysis of the diagnostic process of myasthenia gravis in a specialized clinic.
Neuromuscular disorders : NMD·2025
Combined David procedure and mitral valve repair in Marfan syndrome with mitral annular disjunction.
Multimedia manual of cardiothoracic surgery : MMCTS·2025
Enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer: results of the EORTC 1333/PEACE-3 trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Analysis of drugs of abuse and contaminants in individuals under drug surveillance programs: A study in hair samples.
Forensic science international·2025
Epidemiology of Obstructive Sleep Apnea in Chile: A Systematic Review and Meta-Analysis.
Revista medica de Chile·2026
Rescue of a Discarded Liver Graft Through Viability Assessment Using Normothermic Ex Vivo Machine Perfusion.
Revista medica de Chile·2026
ASO Editorial: Lymph Node Dissection in the Immunotherapy Era: Friend or Foe?
Annals of surgical oncology·2026
[Analysis of clinicopathological and immunological characteristics of patients with acquired immune deficiency syndrome-associated diffuse large B-cell lymphoma complicated by Talaromyces marneffei infection].
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2026
Real-World Experience With TRBC1 Immunohistochemistry Across Cutaneous T-Cell Lymphoma Subtypes:A Large Cohort Study.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Phase II trial of First-Line Axitinib Plus Nivolumab in Patients with Advanced Mucosal Melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026